A Study of Anti-PD-L1 Antibody in Neoadjuvant Chemotherapy of Esophageal Squamous Cell Carcinoma.
Clinical trial NCT04460066 · UNKNOWN
Trial details
- NCT number
- NCT04460066
- Sponsor
- Lee's Pharmaceutical Limited
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-18
- Primary completion
- 2021-12-06
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.